Operose Advisors’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-337
Closed -$13.7K – 510
2024
Q3
$13.7K Sell
337
-254
-43% -$9.55K ﹤0.01% 452
2024
Q2
$20.5K Hold
591
– – 0.01% 351
2024
Q1
$22.2K Hold
591
– – 0.01% 371
2023
Q4
$21.2K Sell
591
-513
-46% -$19.8K 0.01% 357
2023
Q3
$41.7K Buy
1,104
+850
+335% +$34.6K 0.02% 342
2023
Q2
$10.3K Hold
254
– – ﹤0.01% 278
2023
Q1
$10.6K Hold
254
– – 0.01% 266
2022
Q4
$11K Hold
254
– – 0.01% 271
2022
Q3
$10K Hold
254
– – 0.01% 258
2022
Q2
$12K Hold
254
– – 0.01% 226
2022
Q1
$12K Sell
254
-102
-29% -$4.32K 0.01% 252
2021
Q4
$15K Buy
+356
New +$13.4K 0.01% 229

Other funds holding EXC

Operose Advisors's EXC Position: Q4 2024 in Review

Operose Advisors sold out of Exelon (EXC) in Q4 2024, closing a stake of 337 shares — an estimated $13.7K sold.

Operose Advisors first reported a position in EXC in Q4 2021 and held it in 12 quarters. The position peaked at $41.7K in Q3 2023. 1,103 funds tracked by Wall St. Rank hold EXC as of Q4 2024.

  • Operose Advisors reported no remaining Exelon position as of Q4 2024 after selling out during the quarter.
  • Operose Advisors sold 337 Exelon shares in Q4 2024, an estimated $13.7K.
  • Operose Advisors first reported a position in Exelon in Q4 2021 and held it in 12 quarters.
  • Operose Advisors's Exelon position peaked at $41.7K in Q3 2023.
  • 1,103 funds tracked by Wall St. Rank held Exelon as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.